Showing results (81-90 of 412) with videos related to
Sort By:
Pageof 42
Blood|May 27, 2014
Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemiaSteven P Treon, Christina K Tripsas, Kirsten Meid, et al.Blood Advances|July 17, 2025
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemiaJorge J Castillo, Alberto Guijosa, John N Allan, et al.The Oncologist|May 24, 2012
Diagnosis and management of hyponatremia in cancer patientsJorge J Castillo, Marc Vincent, Eric JusticeJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Meta-analysis of the association between cigarette smoking and incidence of Hodgkin's LymphomaJorge J Castillo, Samir Dalia, Helen ShumBritish Journal of Haematology|March 13, 2021
Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenström macroglobulinaemiaJoshua N Gustine, Lian Xu, Guang Yang, et al.Hematology/Oncology Clinics of North America|June 24, 2019
Lymphoplasmacytic Lymphoma and Marginal Zone LymphomaLuis M Juárez-Salcedo, Jorge J CastilloExpert Review of Anticancer Therapy|April 3, 2025
Current and emerging treatment perspectives for adults with Waldenström macroglobulinemiaAlberto Guijosa, Shayna Sarosiek, Jorge J CastilloHematology/Oncology Clinics of North America|September 8, 2018
Monoclonal Antibodies for Waldenström MacroglobulinemiaAndres Dominguez, Efstathios Kastritis, Jorge J CastilloThe Oncologist|February 1, 2023
Managing Ibrutinib-Intolerant Patients With B-Cell MalignanciesJavier Muñoz, Shayna Sarosiek, Jorge J CastilloMediterranean Journal of Hematology and Infectious Diseases|March 14, 2025
Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 2- Focus on TherapyMichele Bibas, Shayna Sarosiek, Jorge J CastilloPageof 42